Literature DB >> 25084796

Ramelteon for the treatment of delirium in elderly patients: a consecutive case series study.

Akihiro Tsuda1, Katsuji Nishimura1, Eiko Naganawa1, Tempei Otsubo2, Jun Ishigooka1.   

Abstract

OBJECTIVE: Melatonin is effective in the prevention and treatment of delirium. Ramelteon has few adverse effects and higher affinity for MT1 and MT2 receptors than melatonin. The aim of the present study was to determine the efficacy of ramelteon in elderly patients with delirium caused by different primary diseases/conditions.
METHOD: We treated 10 consecutive elderly patients having delirium with ramelteon.
RESULTS: Of the 10 patients, six showed improvement, and no marked adverse effects were observed.
CONCLUSIONS: Our study suggested that ramelteon was a safe and useful alternative to melatonin for the treatment of delirium in elderly patients. Randomized, controlled studies are necessary to confirm the therapeutic benefits of ramelteon.

Entities:  

Keywords:  delirium; elderly patients; melatonin; ramelteon

Mesh:

Substances:

Year:  2014        PMID: 25084796     DOI: 10.2190/PM.47.2.a

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  5 in total

1.  Adjunctive treatment with melatonin receptor agonists for older delirious patients with the sundowning phenomenon.

Authors:  Ta-Chuan Yeh; Chin-Bin Yeh; Nian-Sheng Tzeng; Wei-Chung Mao
Journal:  J Psychiatry Neurosci       Date:  2015-03       Impact factor: 6.186

Review 2.  Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.

Authors:  Moshe Laudon; Anat Frydman-Marom
Journal:  Int J Mol Sci       Date:  2014-09-09       Impact factor: 5.923

3.  Clinical Practice Guidelines for Management of Delirium in Elderly.

Authors:  Sandeep Grover; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2018-02       Impact factor: 1.759

4.  Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial.

Authors:  Mitsuaki Nishikimi; Atsushi Numaguchi; Kunihiko Takahashi; Yasuhiro Miyagawa; Kota Matsui; Michiko Higashi; Go Makishi; Shigeyuki Matsui; Naoyuki Matsuda
Journal:  Crit Care Med       Date:  2018-07       Impact factor: 7.598

5.  Melatonin and the Prevention and Management of Delirium: A Scoping Study.

Authors:  Sin Wei Choy; Aun Chian Yeoh; Zhao Zheng Lee; Velandai Srikanth; Chris Moran
Journal:  Front Med (Lausanne)       Date:  2018-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.